At 9:30 a.m., June 29, China’s largest domestic minimally invasive surgical instruments and accessories (MISIA) platform, Kangji Medical, was listed on the main board of the Stock Exchange of Hong Kong, officially ringing the bell for the new journey of Kangji Medical in the capital market.
At the same time, thousands of miles away in the headquarters of Kangji Medical, a grand listing ceremony was held in Tonglu Haibo Hotel. Mao Xihao, Member of the Standing Committee of CPC of Hangzhou City and Head of the Organization Department of CPC of Hangzhou, Fang Yi, Secretary of CPC of Tonglu County, Qi Li, the County Head, Hua Jian, Director of the County People’s Congress, Wang Jincai, Chairman of the County Political Consultative Conference, Zhong Ming, chairman of Kangji Medical, and Shentu Yinguang, vice chairman of Kangji Medical, attended the listing ceremony. They witnessed this remarkable moment together with company employees, distributors, partners, relatives and friends, family members and classmates.

No.1
16 years of history
Kangji Medical, established in 2004, is a high-tech enterprise specializing in the research and development, manufacturing and sales of minimally invasive surgical instruments and accessories (MISIA).

Since our establishment 16 years ago, the company has been providing high-quality products and services for physicians. With a comprehensive and high-quality product portfolio, strong R&D capabilities, demand-oriented product development, extensive distribution network and solid scalable manufacturing capabilities, the company is now the largest domestic platform for minimally invasive surgical instruments and accessories in China.
As of 2019, Kangji Medical’s products have been distributed to more than 3,400 hospitals across the country, including more than 1,000 Class IIIA hospitals. Our distribution network covers all provinces, municipalities and autonomous regions in mainland China, and our products are being distributed to other 42 countries and regions.

No.2
A new page of future
Due to the impact of the COVID epidemic, the gong knocking ceremony was conducted through a cloud-base platform with video connection for this glory moment of Kangji Medical.

Mr. Zhong Ming, Chairman of Kangji Medical, said in the ceremony that IPO of Kangji Medical marked several records. BlackRock, Fidelity, Hillhouse Capital, OrbitMed, Lake Bleu, Cormorant, Oaktree Capital and other world-renowned funds have become cornerstone investors of the company, which indicated the market’s high recognition to Kangji. ”
The success of the IPO also marks that Kangji Medical not only has the endorsement of international capital, but also fuels the company with stronger capital resources and efficient management experience for the future development of Kangji, and opens up future corporate development opportunities for the company.

No.3
Striving together for prosperity
Mr. Qili, Head of the county ,and Mr. Mao Xihao, Head of Organization Department of CPC of Hangzhou City, delivered warm speeches in the ceremony. On behalf of the new and old shareholders, Mr. Chen Gang from LYFE Capital and Ms. Wang Ting from OrbitMed expressed warm congratulations on the successful IPO of Kangji Medical. They said that it is an honor to be the shareholders of Kangji Medical. There are not only leaders like Mr. Zhong and Ms. Shentu who are brave and practical, but also a conscientious executive team. They sincerely hope that Kangji will grow to be a world-class medical device company.

Mr. Zhong Ming said that Kangji Medical will continue to strengthen its R&D capability, optimize its product portfolio, and establish deeper strategic cooperation with surgeons and hospitals, so as to achieve better return and results for shareholders, employees and society!